Severe paroxysmal hypertension (pseudopheochromocytoma)

Current Hypertension Reports

Volumn 10, Issue 1, 2008, Pages 12-18

  Mann, Samuel J ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPRAZOLAM; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CATECHOLAMINE; CLONIDINE; DESIPRAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ILLICIT DRUG; LABETALOL; METADRENALIN; MONOAMINE OXIDASE INHIBITOR; NITROPRUSSIDE SODIUM; NORMETADRENALIN; PSYCHOTROPIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; TYRAMINE;

BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; COMBINATION CHEMOTHERAPY; DEFENSE MECHANISM; DIAPHORESIS; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DRUG BIOAVAILABILITY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; EMOTIONAL STRESS; FOLLOW UP; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; LABILE HYPERTENSION; MAINTENANCE THERAPY; MENTAL DISEASE; MONOTHERAPY; NAUSEA; PANIC; PAROXYSMAL HYPERTENSION; POSTTRAUMATIC STRESS DISORDER; PRESSORECEPTOR; PSEUDOPHEOCHROMOCYTOMA; PSEUDOTUMOR; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; QUALITY OF LIFE; RADIODIAGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; THORAX PAIN; UNSPECIFIED SIDE EFFECT; WEAKNESS;

ADRENAL GLAND NEOPLASMS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; DIAGNOSIS, DIFFERENTIAL; EMOTIONS; HUMANS; HYPERTENSION; PANIC DISORDER; PHEOCHROMOCYTOMA; PSYCHOTHERAPY; STRESS DISORDERS, POST-TRAUMATIC; SYMPATHETIC NERVOUS SYSTEM;

EID: 39149144837     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-008-0005-2     Document Type: Review

References (20)

1. Pacak K, Linehan WM, Eisenhofer G, et al.: Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 2001, 134:315-329.
2. Manger WM, Gifford RW, eds: Clinical and Experimental Pheochromocytoma, edn 2. Malden, MA: Blackwell Science; 1996:4.
3. Mann SJ: Severe paroxysmal hypertension. An autonomic syndrome and its relationship to repressed emotions. Psychosomatics 1996, 37:444-450.
4. Mann SJ: Severe paroxysmal hypertension (pseudopheochromocytoma): understanding its cause and treatment. Arch Intern Med 1999, 159:670-674.
5. Stein PP, Black HR: A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience. Medicine 1991, 70:46-66.
6. Manger WM, Gifford RW: Pheochromocytoma. In Hypertension: Pathophysiology, Diagnosis, and Management, edn 2. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1995:2225-2244.
7. Grossman A, Pacak K, Sawka A, et al.: Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus? Ann N Y Acad Sci 2006, 1073:332-347.
8. Bravo EL, Tarazi RC, Fouad FM, et al.: Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma. N Engl J Med 1981, 305:623-626.
9. Balon R, Ortiz A, Pohl R, Yeragani VK: Heart rate and blood pressure during placebo-associated panic attacks. Psychosom Med 1988, 50:434-438.
10. Kaplan NM: Anxiety-induced hyperventilation. A common cause of symptoms in patients with hypertension. Arch Intern Med 1997, 157:945-948.
11. Kosten TR, Mason JW, Gillen EL, et al.: Sustained urinary norepinephrine and epinephrine elevation in post-traumatic stress disorder. Psychoneuroimmunology 1987, 12:13-20.
12. Kuchel O, Cusson JR, Larochelle P, et al.: Case report: posture- and emotion-induced severe hypertensive paroxysms with baroreceptor dysfunction. J Hypertens 1987, 5:277-283.
13. Aksamit TR, Floras JS, Victor RG, et al.: Paroxysmal hypertension due to sinoaortic baroreceptor denervation in humans. Hypertension 1987, 9:309-314
14. Kuchel O, Buu NT, Larochelle P, et al.: Episodic dopamine discharge in paroxysmal hypertension. Page's syndrome revisited. Arch Intern Med 1986, 146:1315-1320.
15. Frohlich ED, Tarazi RC, Dustan HP: Hyperdynamic beta-adrenergic circulatory state: increased beta-receptor responsiveness. Arch Intern Med 1969, 123:1-7.
16. Streeten DH, Anderson GH Jr, Lebowitz M, et al.: Primary hyperepinephrinemia in patients without pheochromocytoma. Arch Intern Med 1990, 150:1528-1533.
17. McNeil JJ, Anderson AE, Louis WJ, Morgan DJ: Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects. Br J Clin Pharmacol 1979, 8(Suppl 2): 157S-161S.
18. Mann SJ: Neurogenic essential hypertension revisited: the case for increased clinical and research attention. Am J Hypertens 2003, 16:881-888.
19. Morgan T: Clinical pharmacokinetics and pharmacodynamics of carvedilol. Clin Pharmacokinet 1994, 26:335-346.
20. Mann SJ, Gerber LM: Low dose alpha/beta blockade in the treatment of essential hypertension. Am J Hypertens 2001, 14:553-558.